DDLABi001-A

Registration Summary:

A P E C

FD1(cor)

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	DDLABi001-A
Cite as:	DDLABi001-A (RRID:CVCL_C6TR)
Alternative name(s)	FD1(cor)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	24th June 2022
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Korea Advanced Institute of Science and Technology (DDLAB)
External Databases
Cellosaurus	CVCL_C6TR
Wikidata	Q117704330
General Information
Publications	Do HS et al. Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells. EBioMedicine. 2020 Feb;52:102633. Choi JB et al. Generation of a CRISPR/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having α-galactosidase (GLA) gene mutation (c.803_806del). Stem cell research. 2023 Feb;66:103001. Choi JB et al. Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease. Molecular therapy : the journal of the American Society of Gene Therapy. 2023 Apr 5;31(4):1002-1016. Choi Jong Bin et al. Therapeutic effects of lomerizine on vasculopathy in Fabry disease. Scientific Reports. 2025-04-02.

hIPSC Derivation

General